Latest news and insights on the pharmaceutical industry | Indian Pharma Post
Merck Life Science on X: "The battle against cancer is long and arduous. However, HPAPIs, or Highly Potent Active Pharmaceutical Ingredients, can be a powerful weapon against cancer. Hear from our Head
Équipe dirigeante
Dirk T. Lange - MilliporeSigma | LinkedIn
Dirk T. Lange على LinkedIn: Merck Group | Q3 2022 Results
Dirk T. Lange on LinkedIn: Today marks a new chapter for me as I join an organization with so much… | 209 comments
Dirk T. Lange on LinkedIn: One of our strategic priorities continues to be strengthening our…
Merck KGaA forms new life sciences unit in push to strengthen its CDMO position | Fierce Pharma
MilliporeSigma Reorganizes And Adopts New Operating Model | Contract Pharma
CDMO : Merck va doubler sa production d'HPAPI aux États-Unis
Dirk T. Lange - MilliporeSigma | LinkedIn
MilliporeSigma talks CDMO competition - BioProcess InsiderBioProcess International
Merck restructures to strengthen CDMO business
Équipe dirigeante
MilliporeSigma opens 70,000 square foot expansion in Verona | Madison365
Dirk T. Lange - MilliporeSigma | LinkedIn
Merck increases global commitment to biosafety testing with €35 million investment in Scotland | Glasgow Chamber of Commerce
Dirk T. Lange on LinkedIn: Biologics Testing Center Shanghai - News | Merck KGaA, Darmstadt, Germany
Merck Becomes First CTDMO to Offer Comprehensive mRNA Development and Manufacturing Services
Dirk Lange
Dirk T. Lange - MilliporeSigma | LinkedIn
Say hello to a “CTDMO” - Molecule to Market
Dirk Lange
Dirk T. Lange on LinkedIn: Dirk Lange Reveals Merck's Historic Leap as the First CTDMO to Offer… | 12 comments
Q&A: Dirk Lange, president and CEO of KBI Biopharma, talks about biotech growth in The Woodlands | Community Impact
